| Literature DB >> 36009719 |
Félix Goyache1, Lucía Pérez-Pardal2, Iván Fernández1, Amadou Traoré3, Nuria A Menéndez-Arias1, Katherine D Arias1, Isabel Álvarez1.
Abstract
A total of 106 West African taurine cattle belonging to the Lagunaire breed of Benin (33), the N'Dama population of Burkina Faso (48), and N'Dama cattle sampled in Congo (25) were analyzed for Copy Number Variations (CNVs) using the BovineHDBeadChip of Illumina and two different CNV calling programs: PennCNV and QuantiSNP. Furthermore, 89 West African zebu samples (Bororo cattle of Mali and Zebu Peul sampled in Benin and Burkina Faso) were used as an outgroup to ensure that analyses reflect the taurine cattle genomic background. Analyses identified 307 taurine-specific CNV regions (CNVRs), covering about 56 Mb on all bovine autosomes. Gene annotation enrichment analysis identified a total of 840 candidate genes on 168 taurine-specific CNVRs. Three different statistically significant functional term annotation clusters (from ACt1 to ACt3) involved in the immune function were identified: ACt1 includes genes encoding lipocalins, proteins involved in the modulation of immune response and allergy; ACt2 includes genes encoding coding B-box-type zinc finger proteins and butyrophilins, involved in innate immune processes; and Act3 includes genes encoding lectin receptors, involved in the inflammatory responses to pathogens and B- and T-cell differentiation. The overlap between taurine-specific CNVRs and QTL regions associated with trypanotolerant response and tick-resistance was relatively low, suggesting that the mechanisms underlying such traits may not be determined by CNV alterations. However, four taurine-specific CNVRs overlapped with QTL regions associated with both traits on BTA23, therefore suggesting that CNV alterations in major histocompatibility complex (MHC) genes can partially explain the existence of genetic mechanisms shared between trypanotolerance and tick resistance in cattle. This research contributes to the understanding of the genomic features of West African taurine cattle.Entities:
Keywords: Bos taurus; Lagunaire cattle; N’Dama cattle; copy number variations; enrichment analysis; functional clustering; humid West Africa
Year: 2022 PMID: 36009719 PMCID: PMC9405125 DOI: 10.3390/ani12162130
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 3.231
Figure 1Bidimensional-scaling plot illustrating the dispersion of the West African taurine and zebu cattle genotypes. MDS was performed on the between-individuals identity-by-state distance matrix. Taurine cattle are in squares: light green, N’Dama of Congo; dark red, N’Dama of Burkina Faso; and blue, Lagunaire. Zebu cattle dispersion (in circles: blue, Bororo; purple, Zebu Peul of Benin; and orange, Zebu Peul of Burkina Faso) iszoomed in to illustrate the genomic homogeneity of these individuals.
Figure 2Venn diagram (Plot (A)) illustrating the number of candidate Copy Number Variation Regions (CNVRs) identified across type of cattle, constructed using an online tool [41]. Below, the histogram on the left (Plot (B)) illustrates the number of taurine-specific CNVRs (in blue), zebu-specific CNVRs (in red), and CNVRs shared between both cattle types (in green) per CNVR length class. Furthermore, the histogram on the right (Plot (C)) illustrates the total genome length (in Mb) covered by the CNVRs identified per type of cattle and CNVR length class.
Figure 3Ideogram illustrating, per bovine autosome, the distribution of the candidate taurine-specific (in red) and the zebu-specific (in blue) Copy Number Variations Regions (CNVRs) identified.
Significantly enriched functional annotation clusters and functional terms identified in West African taurine cattle.
| Functional Cluster (Enrichment Score) | Category | Term and Description | Genes a | Fold Enrichment | |
|---|---|---|---|---|---|
| Annotation Cluster 1 (2.27) | INTERPRO | IPR011038: Calycin-like | 2.28 × 10−3 | 5.08 | |
| INTERPRO | IPR000566: Lipocalin/cytosolic fatty-acid binding protein domain | 7.28 × 10−3 | 4.85 | ||
| INTERPRO | IPR012674: Calycin | 9.22 × 10−3 | 4.59 | ||
| Annotation Cluster 2 (1.47) | SMART | SM00449: SPRY |
| 2.86 × 10−2 | 2.99 |
| INTERPRO | IPR003877: SPla/RYanodine receptor SPRY | 0.031 | 2.96 | ||
| INTERPRO | IPR001870:B30.2/SPRY domain | 0.044 | 2.71 | ||
| Annotation Cluster 3 (1.44) | INTERPRO | IPR016186:C-type lectin-like | 2.93× 10−2 | 2.47 | |
| SMART | SM00034: CLECT | 0.036 | 2.56 | ||
| INTERPRO | IPR001304:C-type lectin | 3.98 × 10−2 | 2.51 | ||
| INTERPRO | IPR016187:C-type lectin fold | 4.28 × 10−2 | 2.29 |
a name of the gene retrieved from the Ensembl Genes 91 database. If only the Gene Stable ID was available, it is provided instead.
Figure 4Circular map summarizing information on the three significantly enriched functional clusters identified in West African taurine cattle. Chromosomes are shown in the outermost circle. Candidate genes belonging to the significantly enriched functional annotation clusters are indicated next to their genomic localization. At the center of the map, links among candidate genes belonging to the same functional cluster are illustrated using the same color: ACt1 in light green; ACt2 in red; and ACt3 in dark green.
List of trypanotolerance-related and tick-resistance QTL overlapping with the candidate CNVRs identified in West African taurine cattle (CNVRt). The bovine chromosome (BTA) on which the QTL was identified; the position (in bp) for the start and end of the QTL; the QTL identification as obtained from the cattle QTL database [40]; the description of the trait associated with the QTL; and the candidate genes located in the CNVRs, including the functional annotation cluster (AC) they were assigned, are provided. Four CNVRs overlapping with both trypanotolerance and tick-resistance QTL are highlighted in bold.
| Candidate CNVR | BTA | QTL Start (bp) | QTL End (bp) | QTL_ID | Trait | Candidate Genes |
|---|---|---|---|---|---|---|
| CNVRt4 | 1 | 12,484,941 | 34,327,730 | 10506 | Initial packed red blood cell volume a | |
| CNVRt195 | 11 | 104,664,393 | 104,664,433 | 101155 | Tick resistance c | |
| 101169 | Tick resistance c | |||||
| CNVRt214 | 13 | 17,709,118 | 53,561,417 | 10524 | Percentage decrease in PCV up to day 100 after challenge a | |
| 10525 | Percentage decrease in PCV up to day 100 after challenge a | |||||
| 10526 | Parasite detection rate a | |||||
| CNVRt303 | 20 | 12,158,768 | 22,679,451 | 10537 | PCVI minus PCVM a | |
| 10538 | PCV variance a | |||||
| 10539 | Percentage decrease in PCV up to day 100 after challenge a | |||||
| 10540 | Percentage decrease in body weight up today 150 after challenge a | |||||
| 10541 | Parasite natural logarithm of mean number a | |||||
| CNVRt321 | 22 | 4,775,998 | 28,467,455 | 10542 | Initial packed red blood cell volume a | |
| CNVRt334 | 23 | 4,584,848 | 29,554,995 | 10543 | Parasite detection rate a |
|
| CNVRt335 | 23 | 4,584,848 | 29,554,995 | 10543 | Parasite detection rate a | |
|
| 23 | 4,584,848 | 29,554,995 | 10543 | Parasite detection rate a | |
| 13,002,524 | 13,489,143 | 164932 | Tick resistance d | |||
| 13,002,524 | 13,489,143 | 164933 | Tick resistance d | |||
|
| 23 | 4,584,848 | 29,554,995 | 10543 | Parasite detection rate a | ENSBTAG00000048364, ENSBTAG00000038397, ENSBTAG00000015565 (AC30), |
| 22,432,428 | 29,658,279 | 12223 | Tick resistance b | |||
|
| 23 | 4,584,848 | 29,554,995 | 10543 | Parasite detection rate a | ENSBTAG00000054439, |
| 22,432,428 | 29,658,279 | 12223 | Tick resistance b | |||
| 28,511,975 | 39,129,003 | 12224 | Tick resistance b | |||
|
| 23 | 4,584,848 | 29,554,995 | 10543 | Parasite detection rate a | |
| 22,432,428 | 29,658,279 | 12223 | Tick resistance b | |||
| 28,511,975 | 39,129,003 | 12224 | Tick resistance b | |||
| CNVRt345 | 23 | 28,511,975 | 39,129,003 | 12224 | Tick resistance b | |
| CNVRt346 | 23 | 28,511,975 | 39,129,003 | 12224 | Tick resistance b | ENSBTAG00000038430, |
| CNVRt349 | 24 | 14,587,194 | 22,401,178 | 10544 | Initial packed red blood cell volume a | ENSBTAG00000044087 |
| 10544 | Percentage decrease in PCV up to day 100 after challenge a | |||||
| CNVRt364 | 26 | 5,469,941 | 18,747,171 | 10548 | Percentage decrease in PCV up to day 100 after challenge a |
|
| 10549 | Percentage decrease in PCV up to day 100 after challenge a | |||||
| 10550 | BWF scaled by BWI a | |||||
| 10551 | Body weight (mean) a | |||||
| 10552 | Percentage decrease in body weight up today 150 after challenge a | |||||
| CNVRt369 | 27 | 13,701,246 | 20,999,044 | 10553 | PCVI minus PCVM a | |
| 10554 | PCV variance a | |||||
| 10555 | Percentage decrease in PCV up to day 100 after challenge a | |||||
| 10556 | Percentage decrease in PCV up to day 100 after challenge a |
a QTL reported by Hanotte et al. [10]; b QTL reported by Machado et al. [42]; c QTL reported by Mapholi et al. [44]; d QTL reported by Otto et al. [43].